Advertisement

Drugs

, Volume 78, Issue 4, pp 523–524 | Cite as

Correction to: Outcomes Associated with Generic Drugs Approved Using Product-Specific Determinations of Therapeutic Equivalence

  • Joshua J. Gagne
  • Jennifer M. Polinski
  • Wenlei Jiang
  • Sarah K. Dutcher
  • Jing Xie
  • Joyce Lii
  • Lisa A. Fulchino
  • Aaron S. Kesselheim
Correction
  • 398 Downloads

1 Correction to: Drugs 77(4): 427–433 (2017)  https://doi.org/10.1007/s40265-017-0696-2

Page 432, Fig. 2 Plots of model-based outcome incidence rates (per 100 person-years of exposure) before and after introduction of first generic versions of study and control drugs.

Previously presented as:

Open image in new window

Should be presented as:

Open image in new window

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Joshua J. Gagne
    • 1
  • Jennifer M. Polinski
    • 1
  • Wenlei Jiang
    • 2
  • Sarah K. Dutcher
    • 2
  • Jing Xie
    • 1
  • Joyce Lii
    • 1
  • Lisa A. Fulchino
    • 1
  • Aaron S. Kesselheim
    • 1
  1. 1.Program on Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of MedicineBrigham and Women’s Hospital and Harvard Medical SchoolBostonUSA
  2. 2.Office of Generic DrugsCenter for Drug Evaluation and Research, US Food and Drug AdministrationSilver SpringUSA

Personalised recommendations